|
|
||||||||
Division of Nuclear Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Correspondence: For correspondence or reprints contact: Sydney Heyman, MD, Division of Nuclear Medicine, Children's Hospital of Philadelphia, 34th St. and Civic Center Boulevard, Philadelphia, PA 19104.
ABSTRACT
A Meckel's scan was performed on a 7-yr-old boy because of rectal bleeding. He was premedicated with pentagastrin (6 µg/kg subcutaneously) followed by 259 MBq (7 mCi) [99mTc]pertechnetate intravenously. The study was essentially negative. Because of persistent rectal bleeding and a strong clinical suspicion of a Meckel's, a repeat study was performed 6 wk later. He received pentagastrin as before, but this time was also given a histamine H2 receptor blocker (zantac). A Meckel's diverticulum was clearly evident.
Key Words: Meckel's diverticulum pentagastrin
This article has been cited by other articles:
![]() |
F. Saremi, H. Jadvar, and M. E. Siegel Pharmacologic Interventions in Nuclear Radiology: Indications, Imaging Protocols, and Clinical Results RadioGraphics, May 1, 2002; 22(3): 477 - 490. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |